Exchange: NASDAQ·Updated 07:45 PM EDT
FTRE logo

FTREFortrea Holdings Inc. Common Stock

$17.91
$0.18
(1.01%)
Today
Closed $17.91
$0.35
(1.95%)
After Hours
EarningsJul 29
Mkt Cap$1.68B
Vol1.53M
News
all
press releases
Royalty Pharma PLC (RPRX) Hits Fresh High: Is There Still Room to Run?
Royalty Pharma (RPRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks
More News
Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN
Biotech is gaining momentum as healthcare leads higher, with several drugmakers and life sciences companies showing improving earnings trends and breakouts.
Zacks
Agilent Strengthens Biopharma Growth Prospects With AI Expansion
A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.
Zacks
Stocks Look Shaky, But This Sector is Booming (Biotech)
Biotechnology stocks like Illumina, Eli Lilly and Exelixis have quietly turned into the new market leaders.
Zacks
FTRE or ARGX: Which Is the Better Value Stock Right Now?
FTRE vs. ARGX: Which Stock Is the Better Value Option?
Zacks
New Strong Buy Stocks for July 7th
DEC, FTRE, HG, PARR and KE have been added to the Zacks Rank #1 (Strong Buy) List on July 7, 2026.
Zacks
Fortrea Appoints Jason Knoblauch To Succeed Jill McConnell As CFO
(RTTNews) - Contract research organization Fortrea Holdings, Inc. (FTRE) announced Friday that Jason Knoblauch has been appointed as chief financial officer, effective July 6, 2026. He will succeed Jill McConnell, who is stepping down, and is committed to ensuring a smooth transi...
Nasdaq News: Markets
Fortrea Q1 Earnings Call Highlights
Fortrea (NASDAQ:FTRE) reported first-quarter 2026 results that management said reflect improving commercial traction, operational execution, and ongoing cost discipline, while the contract research organization reiterated its full-year guidance. Management cites stabilizing demand and sustained boo...
MarketBeat
Fortrea (NASDAQ:FTRE) Shares Gap Up After Better-Than-Expected Earnings
Fortrea (NASDAQ:FTRE) Shares Gap Up on Earnings Beat...
MarketBeat
Fortrea (NASDAQ:FTRE) Releases Quarterly Earnings Results, Beats Estimates By $0.13 EPS
Fortrea (NASDAQ:FTRE - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.